María del Carmen Navarro*, Pedro Saavedra, Esteban Jódar, Mª Jesús Gómez de Tejada, Ana Mirallave and Manuel Sosa **
|
|
- Norman McKenzie
- 8 years ago
- Views:
Transcription
1 Clinical Endocrinology (2013) 78, doi: /cen ORIGINAL ARTICLE Osteoporosis and metabolic syndrome according to socioeconomic status, contribution of PTH, vitamin D and body weight: The Canarian Osteoporosis Poverty Study (COPS) María del Carmen Navarro*, Pedro Saavedra, Esteban Jódar, Mª Jesús Gómez de Tejada, Ana Mirallave and Manuel Sosa ** *Research Group on Education and Promotion of Health, University of Las Palmas de Gran Canaria, Department of Mathematics, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Canary Islands, Endocrinology Service, University Hospital Quirón Madrid, European University Madrid, Madrid, Department of Medicine, University of Seville, Seville, Research Group on Osteoporosis and Bone Mineral Diseases, University of Las Palmas de Gran Canaria and **Bone Metabolic Unit, Insular University Hospital, Las Palmas de Gran Canaria, Canary Islands, Spain Summary Correspondence: Esteban Jódar, Servicio de Endocrinología y Nutrición Clínica, Hospital Universitario Quirón Madrid, C/ Diego de Velazquez 2, Pozuelo de Alarcón, 28223, Madrid, Spain. Fax: ; Tel.: ; esteban.jodar@gmail.com Competing interests: Nothing to declare. Background Poverty is associated with a great number of diseases, but the prevalence of vitamin D deficiency, secondary hyperparathyroidism and the potential association of osteoporosis, osteoporotic fractures and metabolic syndrome in this situation are less well known. Objective To evaluate the associations between poverty, bone density, fragility fractures and metabolic syndrome in a population of southern European postmenopausal women. Also, to assess the potential role of vitamin D and parathyroid hormone (PTH) levels in these associations. Method Cross-sectional study was carried out in postmenopausal Caucasian Spanish women. The socio-economic status of the participants was determined after a personal interview, according to the criteria of the Spanish Institute of Statistics. Participants were divided into two socio-economic levels: low (poverty) and medium or high socioeconomic level. The study protocol included a health questionnaire, a complete physical examination, lateral radiograph of the dorsal and lumbar spine and measurement of bone mineral density (BMD) at the lumbar spine (L2-L4) and proximal femur. Fasting blood was obtained to measure 25-hydroxy-vitamin D (25-OHD), intact PTH and selected biochemical variables. Results Low socio-economic status was associated with 25-OHD insufficiency, higher values of PTH, higher body weight and body mass index (BMI), lower values of BMD at the lumbar spine and a higher prevalence of fragility fractures, both vertebral and nonvertebral. Poverty was also associated with higher prevalence of metabolic syndrome, but this association was driven mainly by the higher BMI and not by poverty itself. Both vitamin D insufficiency and elevated PTH were consistently related to poverty and osteoporotic fractures. Conclusions Poor postmenopausal women in southern Europe have a high prevalence of metabolic syndrome and osteoporotic fractures. Poverty was associated with higher BMI and metabolic syndrome on the one hand and, on the other, with 25OHD insufficiency, higher PTH levels and osteoporosis. 25OHD insufficiency and/or secondary hyperparathyroidism do not have a significant influence on the presence of metabolic syndrome in this population. (Received 23 May 2012; returned for revision 23 August 2012; finally revised 31 August 2012; accepted 16 September 2012) Introduction Vitamin D is required for adequate absorption of dietary calcium and for mineralization of bone. The first well-known clinical entities associated with vitamin D deficit were rickets and osteomalacia. Nowadays, less severe vitamin D deficiency, often described as vitamin D insufficiency or inadequacy, 1,2 is much more frequent and causes stimulation of the parathyroid glands, which may lead to high bone turnover, bone loss and hip fractures. 3,4 More recently, low serum 25-hydroxy-vitamin D (25-OHD) has been implicated in the development of a number or diseases including diabetes, hypertension and metabolic syndrome. 5, 6 On the other hand, poverty is one of the biggest public health problems today. 7 In this particular population low income, the elderly or children the existence of vitamin D insufficiency has been previously described and may lead to the development of secondary hyperparathyroidism and an increase in bone turnover. 8, 9 681
2 682 M. d. C. Navarro et al. We have previously published the finding that fragility fractures are more frequent in poor postmenopausal women. 10 The aim of this study was to evaluate the associations between poverty, bone density, fragility fractures and metabolic syndrome and to assess the potential role of vitamin D and PTH levels in these associations in a population of southern European postmenopausal women. Methods Subjects Between January 2007 and January 2009, postmenopausal Caucasian women attending a metabolic bone clinic in the Spanish public health system (Canary Islands; Latitude/Longitude 28 o 06 N, 15 o 24 W) as outpatients were included in this study. The inclusion criteria were as follows: age between 40 and 85 years, being born and resident in the Canary Islands, postmenopausal state last menstrual period at least one year previously, and having given written informed consent. Medications likely to influence skeletal metabolism or the interpretation of results (i.e. thiazides, hormonal replacement therapy) were recorded. Women treated with anti-osteoporosis medications including calcium and vitamin D supplements and those with known malabsorption, cancer or other serious diseases were excluded from the study. The participants were referred from Gynaecology, Endocrinology and Internal Medicine Services after ruling out secondary causes of osteoporosis. The younger women had suffered a bilateral oophorectomy without malignancy. The Ethics Committee of the Insular University Hospital of Gran Canaria approved the study. A previously validated questionnaire concerning health, diet, drug use, lifestyle and reproductive history was obtained. 11 A complete physical examination was also performed. The socioeconomic status of the participants was stated after a personal interview, following the criteria of the Spanish Institute of Statistics (poverty is defined as an annual income lower than Euros per capita/family member). 12 Estimated calcium intake was assessed using a validated questionnaire. 13 Biochemical measurements Serum specimens were obtained after an overnight fast. Blood was collected without additives between 800 and 900 a.m. After centrifugation at g for 10 min, serum was aliquoted and frozen at 20 C within 1 h of phlebotomy until the biochemical analyses were performed. Glucose, urea, calcium, phosphorus, alkaline phosphatase, albumin, creatinine, total-, HDL- and LDL cholesterol and triglycerides were analysed by standard methods. Filtration rate (GFR) was estimated according to MDRD-4 (GFR (MDRD-4) = (Cr age 0203 ) ) as recommended by the National Kidney Foundation practice guideline 14 for Caucasian women. Serum parathyroid hormone (PTH) and 25-hydroxy-vitamin D (25-OHD) were measured by electrochemiluminescence with Elecsys 170 PP (Modular Analytics) of Roche Diagnostic (Basel, Switzerland). Bone mass and osteoporotic fracture assessment Bone mass was assessed by dual-energy X-ray absorptiometry (DXA) at lumbar spine (L 2 L 4 ) and femoral neck, with a Hologic QDR-4500 densitometer. Precision was 075 ± 016% with a densitometric range of 06 11%. Values were compared to national standards. 15 All measurements were made by the same operator, to limit interobserver variation. Prevalent vertebral fractures were assessed on standard lateral spine radiographs in all subjects. Vertebral fractures were defined following the radiological semiquantitative criteria of Genant. 16 The presence of nonvertebral fractures was documented by a self-reported history with later confirmation in medical hospital records or X-ray films. Statistical analysis The categorical variables were summarized as percentages and the continuous ones as means and standard deviations when the data followed a normal distribution or medians and interquartile range (IQR) when they did not. Logarithmic relationship between serum 25-OHD and PTH levels was calculated. To assess the differences between the subjects with low and medium high socio-economical status, percentages were compared using the chi-square test, means by the t-test and medians by the Wilcoxon test. For DXA results, means were adjusted by age and BMI and compared using the corresponding F-test. Fracture rates were adjusted by age using logistic regression. Logistic regression analysis using a retrospective method based on the Akaike s information criterion was performed to study the association between poverty and the study variables. This analysis was repeated for the presence of metabolic syndrome. The resulting model was summarized in P-values and adjusted odd ratios, which were estimated by 95% CIs. Statistical significance was set at P < 005. Data were analysed with the SPSS statistical program (150, SPSS, Chicago, IL, USA). Results Women were placed into two groups according to their socioeconomic status: poverty and medium or high economic status. Table 1 shows the characteristics of our population. Poorer postmenopausal women were older and had higher values of BMI than women from medium and high economic status. Poorer menopausal women showed a higher rate of alcohol and tobacco consumption and thiazide use and lower rates of HRT. They also showed higher PTH and lower 25-OHD levels. Although more than 80% of poor postmenopausal women had 25-OHD values lower than 30 ng/ml, the prevalence of 25-OHD insufficiency was also high (692%) in postmenopausal women with medium to high economic status. 190% of women in poverty had high levels of PTH secondary hyperparathyroidism vs 140% in the other group, and PTH levels were 25% higher in poor women compared to the other group. The adjustment of 25-OHD levels according to the season of the extraction of the sample did not change the results (data not
3 Table 1. Characteristics of the study population according their economic status Poverty, osteoporotic fractures and metabolic syndrome, role of vitamin D insufficiency 683 Poverty Yes n = 474 No n = 776 P value Age (years) 566 ± ± 116 <0001 Weight (kg) 705 ± ± 116 <0001 Height (cm) 156 ± ± 63 <0001 Body mass 291 ± ± 47 <0001 index (kg/m 2 ) Calcium 610 ( ) 650 ( ) 0945 intake (mg/24 h) Alcohol <0001 consumption (%) Tobacco <0001 consumption (%) HRT use (%) Thiazides use (%) Low physical activity (%) PTH (pg/ml)* 409 ( ) 373 ( ) 0001 PTH > pg/ml (%) 25-OHD (ng/ml)* 21 (17 25) 25 (21 32) < OHD status (%) <50 nmol/l (%) < nmol/l (%) >75 nmol/l (%) Obesity (%) <0001 Diabetes mellitus (%) Hypertension (%) Total cholesterol 244 ± ± (mg/dl) LDL cholesterol 163 ± ± (mg/dl) HDL cholesterol 53 (43 62) 57 (48 69) <0001 (mg/dl)* Triglycerides 121 (91 171) 107 (82 151) 0001 (mg/dl)* Metabolic syndrome (%) MDRD-4 (ml/min/173 m 2 )* 656 ( ) 640 ( ) 0119 Data are expressed as mean ± SD except as marked: (*) Median (interquartile range); HRT, hormone replacement therapy; 25-OHD, 25-hydroxy-vitamin D; MDRD-4, glomerular filtration rate calculated as MDRD (Modification of Diet in Renal Disease) study equation; PTH, parathyroid hormone. shown). PTH and 25-OHD showed a logarithmic relationship (R 2 = 038) (Fig. 1). The prevalence of components of metabolic syndrome and metabolic syndrome itself was also greater among poor women. Interestingly, no differences were found in renal function assessed as MDRD-4. Postmenopausal women with low economic status had lower lumbar spine BMD (Table 2) and higher rates of vertebral and nonvertebral fractures (Table 3). Fig. 1 Logarithmic relationship between serum 25-hydroxy-vitamin D and parathyroid hormone levels (R 2 = 038). Table 2. Comparison of bone mineral density values measured by dualenergy X-ray absorptiometry according to economic status Poverty Yes n = 474 No n = 776 Lumbar spine (L2 L4) g/cm ± ± T score 1648 ± ± 1861 Adjusted mean* 0865 (0008) 0896 (0006) 0003 Femoral neck g/cm ± ± T score 1021 ± ± 1221 Adjusted mean* 0726 (0006) 0729 (0004) 0726 Total Hip g/cm ± ± T score 1197 ± ± 1474 Adjusted mean* 0798 (0006) 0802 (0005) 0569 *Adjusted for age and BMI. Data are expressed as mean ± SD or as mean (SE). BMI, body mass index. The logistic multivariate analysis for the variable poverty is shown in Table 4. The variables with an independent relationship with poverty were BMI, PTH, 25-OHD, MDRD-4 and presence of vertebral fracture. Age, weight, height, alcohol intake, tobacco consumption, HRT and thiazide use did not add any significant information to the model. The presence of metabolic syndrome was strongly associated with BMI (data not shown). To further explore the potential association of metabolic syndrome with PTH and 25-OHD levels, a logistic multivariate analysis for the variable metabolic syndrome was performed (Table 5) but only BMI and age showed independent associations. PTH, 25-OHD and presence of poverty were not independently associated with metabolic syndrome and were excluded from the model. P
4 684 M. d. C. Navarro et al. Table 3. Comparison of fragility fractures (total and vertebral fractures) according to economic level Fractures Discussion Poverty Yes (n = 474) No (n = 776) P value OR (95% CI) Total Crude, n (%) 147 (310) 177 (228) (118; 197) Adjusted* (%) (098; 170) Vertebral Crude, n (%) 87 (193) 81 (122) (124; 239) Adjusted* (%) (108; 113) *Estimated for the mean age of 548 years for each group. Table 4. Multivariate logistic regression. Variables independently associated with the presence of poverty Variable P value OR (95% CI) BMI (per Kg/m 2 ) < (1067; 1132) PTH (per pg/ml) (0976; 0994) 25-OHD (per nmol/l) < (0950; 0969) MDRD-4 (per ml/min/173 m 2 ) (1000; 1011) Vertebral fracture (1257; 2610) BMI, body mass index; 25-OHD, 25-hydroxy-vitamin D; PTH, parathyroid hormone; MDRD-4, glomerular filtration rate calculated with MDRD (Modification of Diet in Renal Disease) study equation; PTH (parathyroid hormone). Table 5. Multivariate logistic regression. Variables independently associated with the presence of metabolic syndrome. Variable P value OR (95% CI) BMI < (1194; 1292) Age < (1014; 1048) BMI, body mass index. We have shown that women with a low socio-economic level have a high prevalence of obesity and metabolic syndrome. These women have a high prevalence of vitamin D insufficiency, which leads to the development of secondary hyperparathyroidism. Vitamin D insufficiency and secondary hyperparathyroidism result in lower BMD and a higher prevalence of vertebral fractures. Nevertheless, 25-OHD insufficiency and secondary hyperparathyroidism were not related to the high prevalence of metabolic syndrome. Although there is a wide controversy related to the optimal levels of 25-OHD as a marker of vitamin D status, 17, 18 vitamin D deficiency has been defined recently by the Endocrine Society as 25-OHD below 20 ng/ml (50 nmol/l) and vitamin D insufficiency as 25-OHD between 21 and 29 ng/ml ( nmol/l). 19 In accordance with these definitions, it has been estimated that % of United States and European elderly men and women 5, still living in the community are vitamin D deficient. Among European postmenopausal women, the prevalence of 25-OHD inadequacy was 796% and 321% when considering cut-offs of 32 and 20 ng/ml (80 and 50 nmol/l), respectively. Interestingly, in the subgroup of patients up to 65 years, the prevalence reached 86% (cut-off of 32 ng/ml) and 45% (cut-off of 20 ng/ml). 23 In our population, the prevalence of vitamin D inadequacy is comparable but two differences must be kept in mind: the first is the mean age of our sample, almost 20 years younger than the sample of the above study 23 ; the second is related to the geographical localization, the Canary Islands being located off the north-western coast of Africa in the southern part of Europe (Latitude/Longitude 28 o 06 N, 15 o 24 W), with a mean of h of sunshine during the last year (more than 190 sunshine hours every month) compared to h/year in Brussels, in Berlin or in Copenhagen. Moreover, in accord with previous studies, 8,9,24 poverty was associated with lower values for 25-OHD, which may be related to the higher BMI in poorer women 25,26 or to nutritional deficiencies associated with poverty. 27 A potential inefficiency of skin production has been suggested but not proven in this population. It is also important to note that the glomerular filtration rate was comparable between our two study groups, which removes the influence of kidney function on vitamin D status. Low 25-OHD and secondary hyperparathyroidism are wellknown factors implicated in osteoporosis and osteoporotic fractures. 5,19,28 In fact, although the poor women in our study were heavier, we have shown lower lumbar BMD and higher rates of osteoporotic fractures in these women. Moreover, there is a difference in the use of thiazide diuretics in the two groups higher in the poorer women which may result in an underestimation of the difference in BMD as thiazides reduce urinary calcium excretion and PTH and increase BMD. 29 In any case, both groups had a very low intake of dietary calcium compared to the recommended dietary reference intakes. 17 This could particularly affect poor women with lower 25-OHD level as shown in US adults. 30 The multivariate analysis identified higher BMI, PTH, GFR, number of fractures and lower 25-OHD as independent factors associated with poverty. Thus, our data support a role for vitamin D deficiency and higher PTH levels as factors implicated in the development of low bone mineral density and osteoporotic fractures in poverty. Vitamin D deficiency has also been linked with diabetes, hypertension, myocardial infarction and stroke, as well as other cardiovascular-related diseases, such as congestive heart failure, peripheral vascular disease or endothelial dysfunction. 6,25 However, few randomized, controlled trials have evaluated the effect of vitamin D replacement on cardiovascular outcomes, and the results have been inconclusive or contradictory. 19,31 The PTH level, but not the vitamin D level, has been proposed as an independent predictor of metabolic syndrome in morbidly obese
5 Poverty, osteoporotic fractures and metabolic syndrome, role of vitamin D insufficiency 685 Caucasian women and men. 32 Our data do not support this view as long as metabolic syndrome prevalence was driven just by age and, mainly, BMI. 25-OHD and PTH did not show any independent association with metabolic syndrome prevalence in the multivariate analyses according to previous cross-sectional studies in overweight and obese adults of different ethnicities. 26 Very recently, in a similar number of older Dutch subjects (mean age 75 years) of both sexes, there was a significantly increased risk of metabolic syndrome in the subjects with 25-OHD insufficiency. 33 The higher prevalence of metabolic syndrome (more than 1/3), the lower BMI and other potential factors such as GFR, age or sex could explain the differences. Thus, the present study highlights the importance of excess body weight over vitamin D status or PTH levels in the development of the metabolic syndrome in young postmenopausal women. There are two main limitations to this study: Firstly, it is a cross-sectional study in which only prevalent osteoporotic fractures or metabolic syndrome prevalence was analysed; thus, prospective studies are necessary to confirm the results. Secondly, the study was conducted in a relatively small sample, not randomly selected from the Canarian population. However, we consider that our sample was representative of the population, because it was composed of subjects who agreed to participate in several epidemiological studies and BMD values obtained at different age groups did not differ from reference values published for the Canarian and Spanish population. 15,34,35 The strength of our study is that there are no previously published studies that establish the association between poverty, vitamin D status, PTH, osteoporosis and metabolic syndrome. In conclusion, poorer postmenopausal women living in southern Europe are more vulnerable to suffering from osteoporotic fractures and metabolic syndrome but, although bone loss and fractures seem to be related to vitamin D insufficiency and high PTH levels, metabolic syndrome prevalence is influenced only by age and BMI. References 1 McKenna, M.J. (1992) Differences in vitamin D status between countries in young adults and the elderly. American Journal of Medicine 93, Chapuy, M.C., Preziosi, P., Maamer, M. et al. (1997) Prevalence of vitamin D insufficiency in an adult normal population. Osteoporosis International 7, Parfitt, A.M., Gallagher, J.C., Heaney, R.P. et al. (1982) Vitamin D and bone health in the elderly. American Journal of Clinical Nutrition 36, Lips, P. & Obrant, K.J. (1991) The pathogenesis and treatment of hip fractures. Osteoporosis International 1, Holick, M.F. (2007) Vitamin D deficiency. New England Journal of Medicine 357, Holick, M.F. (2010) Vitamin D: Extraskeletal health. Endocrinology and Metabolism Clinics of North America, 39, Lessard, R. & Raynault, M.F. (2009). Public health and poverty. Canadian Journal of Public Health 100: Harris, S.S., Soteriades, E. & Dawson-Hughes, B. (2001) Secondary hyperparathyroidism and bone turnover in elderly blacks and whites. Journal of Clinical Endocrinology and Metabolism 86, Cole, C.R., Grant, F.K., Tangpricha, V. et al. (2010) 25-hydroxyvitamin D status of healthy, low-income, minority children in Atlanta, Georgia. Pediatrics 125, Navarro, M.C., Sosa, M., Saavedra, P. et al. (2009) Poverty is a risk factor for osteoporotic fractures. Osteoporosis International 20, Sosa Henriquez, M. (2000) Working group on clinical practice and protocols. Basic data on osteoporosis. Revista Española de Enfermedades Metabólicas Óseas 9, Spanish National Institute of Statistics (2004) Life conditions questionnaire. Main results. INE. Available at prensa/np394pdf, accessed 1 April Cummings, S.R., Block, G., McHenry, K. et al. (1987) Evaluation of two food frequency methods of measuring dietary calcium intake. American Journal of Epidemiology 126, National Kidney Foundation. (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American Journal of Kidney Diseases 39(2 suppl 1), S1 S Diaz Curiel, M., Carrasco de la Pena, J.L., Honorato Perez, J. et al. (1997) Study of bone mineral density in lumbar spine and femoral neck in a Spanish population. Multicentre Research Project on Osteoporosis. Osteoporosis International 7, Genant, H.K., Wu, C.Y., van Kuijk, C. et al. (1993) Vertebral fracture assessment using a semiquantitative technique. Journal of Bone and Mineral Research 8, Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. In: A.C. Ross, C.L. Taylor, A.L. Yaktine, et al., eds. Dietary Reference Intakes for Calcium and Vitamin D. National Academies Press (US), Washington (DC), Available at: books/nbk56070/ [Accessed 9 October 2012]. 18 Heaney, R.P. & Holick, M.F. (2011) Why the IOM recommendations for vitamin D are deficient. Journal of Bone and Mineral Research 26, Holick, M.F., Binkley, N.C., Bischoff-Ferrari, H.A. et al. & Endocrine Society. (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 96, Chapuy, M.C., Schott, A.M., Garnero, P. et al. (1996) Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter: EPIDOS Study Group. Journal of Clinical Endocrinology and Metabolism 81, Holick, M.F., Siris, E.S., Binkley, N. et al. (2005) Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. Journal of Clinical Endocrinology and Metabolism 90, Lips, P., Hosking, D., Lippuner, K. et al. (2006) The prevalence of vitamin D in- adequacy amongst women with osteoporosis: an international epidemiological investigation. Journal of Internal Medicine 260, Bruyère, O., Malaise, O., Neuprez, A. et al. (2007) Prevalence of vitamin D inadequacy in European postmenopausal women. Current Medical Research and Opinion 23, Hirani, V., Mosdøl, A. & Mishra, G. (2009) Predictors of 25- hydroxyvitamin D status among adults in two British national surveys. British Journal of Nutrition 101,
6 686 M. d. C. Navarro et al. 25 Martins,D., Wolf, M., Pan, D.et al. (2007) Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Archives of Internal Medicine 167, McGill, A.T., Stewart, J.M., Lithander, F.E. et al. (2008) Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutrition Journal 7, Castetbon, K., Méjean, C., Deschamps, V. et al. (2011) Dietary behaviour and nutritional status in underprivileged people using food aid (ABENA study, ). Journal of Human Nutrition and Dietetics 24, Pérez-López, F.R., Brincat, M., Erel, C.T. et al. (2012) EMAS position statement: vitamin D and postmenopausal health. Maturitas 71, Bolland, M.J., Ames, R.W., Horne, A.M. et al. (2007) The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporosis International 18, Bischoff-Ferrari, H.A., Kiel, D.P., Dawson-Hughes, B. et al. (2009) Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults. Journal of Bone and Mineral Research 24, McGreevy, C. & Williams, D. (2011) New insights about vitamin D and cardiovascular disease. A narrative review. Annals of Internal Medicine 155, Hjelmesaeth, J., Hofsø, D., Aasheim, E.T. et al. (2009) Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovascular Diabetology 8, Oosterwerff, M.M., Eekhoff, E.M.W., Heymans, M.W. et al. (2011) Serum 25-hydroxyvitamin, D levels and the metabolic syndrome in older persons: a population-based study. Clinical Endocrinology 75, Sosa, M., Hernandez, D., Estevez, S. et al. (1998) The range of bone mineral density in healthy Canarian women by dual X-ray absorptiometry radiography and quantitative computer tomography. Journal of Clinical Densitometry 1, Sosa, M., Saavedra, P., Muñoz-Torres, M. et al. (2002) Quantitative ultra-sound calcaneus measurements: normative data & precision in the Spanish population. Osteoporosis International 13,
Healthy Aging Lab: Current Research Abstracts
Healthy Aging Lab: Current Research Abstracts Arsenic Exposure and Women s Health Environmental exposure to inorganic arsenic is an indisputable source of increased risk of several human cancers and chronic
More informationBULLETIN. Slovak Republic Ministry of Health
BULLETIN Slovak Republic Ministry of Health Part 51-53 November 13, 2009 No. 57 CONTENTS: 52. Slovak Republic Ministry of Health Guidelines for the Diagnosis of Glucocorticoidinduced Osteoporosis 52. Slovak
More informationDERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) OSTEOPOROSIS GUIDELINE
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) OSTEOPOROSIS GUIDELINE This is an updated guideline It incorporates the latest NICE guidance There are strong recommendations for calcium + vitamin D
More informationClinical Policy Guideline
Clinical Policy Guideline Policy Title: Bone Density Testing Policy No: B0215A.00 Effective Date: 01/01/15 Date Reviewed: 03/25/15 I. DEFINITION/BACKGROUND Bone density testing is used to estimate the
More informationModule 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC
Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment William D. Leslie, MD MSc FRCPC Case #1 Age 53: 3 years post-menopause Has always enjoyed excellent health with
More informationVitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr
Vitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr Stefan Pilz Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz, Austria Department
More informationNATIONAL OSTEOPOROSIS FOUNDATION OSTEOPOROSIS CLINICAL UPDATES Bariatric Surgery And Skeletal Health CE APPLICATION FORM
NATIONAL OSTEOPOROSIS FOUNDATION OSTEOPOROSIS CLINICAL UPDATES Bariatric Surgery And Skeletal Health CE APPLICATION FORM First Name: Last Name: Mailing Address: City: State: Zip/Postal Code: Country: Phone
More informationOriginal. Se Hwa Kim 1), Tae Ho Kim 1) and Soo-Kyung Kim 2)
Endocrine Journal 2014 Original Advance Publication doi: 10.1507/endocrj. EJ14-0287 Effect of high parathyroid hormone level on bone mineral density in a vitamin D-sufficient population: Korea National
More informationRenal Disease in Type 2 Diabetes Mellitus
Renal Disease in Type 2 Diabetes Mellitus 6th Collaborative DiGP/HSE/UCC Conference 25 th September 2013 Dr. Eoin O Sullivan Consultant Endocrinologist Bon Secours Hospital Cork Case 69 year old woman
More informationOsteoporosis has been identified by the US Surgeon General
New Guidelines for the Prevention and Treatment of Osteoporosis E. Michael Lewiecki, MD, and Nelson B. Watts, MD Abstract: The World Health Organization Fracture Risk Assessment Tool (FRAX ) and the National
More informationPress Information. Vitamin D deficiency
DSM, Corporate Communications P.O. Box 6500, 6401 HJ Heerlen The Netherlands phone +31 (0) 45 578 2421 www.dsm.com Vitamin D is one of the essential nutrients for human health. Unlike other types of vitamins
More informationPROTOCOL FOR PATIENTS WITH ABNORMAL LAB AND X-RAY VALUES
PROTOCOL FOR PATIENTS WITH ABNORMAL LAB AND X-RAY VALUES Patients newly diagnosed as osteopenic or osteoporotic on a radiology report or patients receiving abnormal lab values on the following lab tests
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: testing_serum_vitamin_d_levels 9/2015 2/2016 2/2017 2/2016 Description of Procedure or Service Vitamin D,
More informationThe Association of Vitamin D Dietary Intake and Type 2 Diabetes Among African Americans in Central Ohio
The Association of Vitamin D Dietary Intake and Type 2 Diabetes Among African Americans in Central Ohio Presenter: Sin Nee Ng Advisors: Dr. Julie Kennel, Dr. Tonya Orchard Copyright 2014 Sin Nee Ng. All
More informationVitamin D Status: United States, 2001 2006
Vitamin D Status: United States, 2001 2006 Anne C. Looker, Ph.D.; Clifford L. Johnson, M.P.H.; David A. Lacher, M.D.; Christine M. Pfeiffer, Ph.D.; Rosemary L. Schleicher, Ph.D.; and Christopher T. Sempos,
More informationNATIONAL OSTEOPOROSIS FOUNDATION OSTEOPOROSIS CLINICAL UPDATES Vitamin D and Bone Health CE APPLICATION FORM
NATIONAL OSTEOPOROSIS FOUNDATION OSTEOPOROSIS CLINICAL UPDATES Vitamin D and Bone Health CE APPLICATION FORM First Name: Last Name: Mailing Address: City: State: Zip/Postal Code: Country: Phone Number:
More informationScans and tests and osteoporosis
Scans and tests and osteoporosis What is osteoporosis? Osteoporosis occurs when the struts which make up the mesh-like structure within bones become thin causing them to become fragile and break easily,
More informationDISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD
STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with
More informationDEFINITION OF OSTEOPOROSIS
CHAPTER 27 OSTEOPOROSIS AND OSTEOMALACIA DEFINITION OF OSTEOPOROSIS THE EPIDEMIOLOGY AND CONSEQUENCES OF OSTEOPOROSIS REVIEW OF BONE REMODELING BONE LOSS PATHOGENESIS OF OSTEOPOROSIS DIAGNOSIS OF OSTEOPOROSIS
More informationClinical Practice Guideline for Osteoporosis Screening and Treatment
Clinical Practice Guideline for Osteoporosis Screening and Treatment Osteoporosis is a condition of decreased bone mass, leading to bone fragility and an increased susceptibility to fractures. While osteoporosis
More information25-hydroxyvitamin D: from bone and mineral to general health marker
DIABETES 25 OH Vitamin D TOTAL Assay 25-hydroxyvitamin D: from bone and mineral to general health marker FOR OUTSIDE THE US AND CANADA ONLY Vitamin D Receptors Brain Heart Breast Colon Pancreas Prostate
More informationOrthopaedic Issues in Adults with CP: If I Knew Then, What I Know Now
Orthopaedic Issues in Adults with CP: If I Knew Then, What I Know Now Laura L. Tosi, MD Director, Bone Health Program Children s National Medical Center Washington, DC Epidemiology 87-93% of children born
More informationMedications for Prevention and Treatment of Osteoporosis
1 Medications for Prevention and Treatment of Osteoporosis Osteoporosis is a disease where the strength of bones is less than normal, making them more susceptible to fracture, or breaking, than normal
More informationOsteoporosis Assessment Using DXA and Instant Vertebral Assessment. Working Together For A Healthier Community
Osteoporosis Assessment Using DXA and Instant Vertebral Assessment Working Together For A Healthier Community Osteoporosis The Silent Thief The Facts About Osteoporosis 1 in 2 women will develop osteoporosis
More informationVitamin D Status and Its Seasonal Variations and Association With Parathyroid Hormone Concentration in Healthy Women in Riga
:329-34 329 Vitamin D Status and Its Seasonal Variations and Association With Parathyroid Hormone Concentration in Healthy Women in Riga Aivars Lejnieks 1, Anda Slaidina 2, Agnis Zvaigzne 3, Una Soboleva
More informationClinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada: Background and Technical Report
Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada: Background and Technical Report Authors: Alexandra Papaioannou MD MSc 1, Suzanne Morin MD MSc 2, Angela M. Cheung
More informationWho should receive calcium and vitamin D supplementation?
Age and Ageing 2012; 41: 576 580 doi: 10.1093/ageing/afs094 Published electronically 8 August 2012 The Author 2012. Published by Oxford University Press on behalf of the British Geriatrics Society. All
More informationFast Facts on Osteoporosis
Fast Facts on Osteoporosis Definition Prevalence Osteoporosis, or porous bone, is a disease characterized by low bone mass and structural deterioration of bone tissue, leading to bone fragility and an
More informationA Treatment Algorithm for Indian Patients of Osteoporosis
Indian Medical Gazette FEBRUARY 2012 67 Symposia Update A Treatment Algorithm for Indian Patients of Osteoporosis Shailendra Mohan Lakhotia, Senior Consultant Orthopedic Surgeon, Kolkata 700 045. Prashant
More informationThe menopausal transition usually has three parts:
The menopausal transition usually has three parts: Perimenopause begins several years before a woman s last menstrual period, when the ovaries gradually produce less estrogen. In the last 1-2 years of
More informationCystic fibrosis and bone health
Cystic fibrosis and bone health Factsheet March 2013 Cystic fibrosis and bone health Introduction As we get older our bones become thinner and weaker, and may become more susceptible to fracture. However
More informationProtein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075
Title: Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075 Investigator: Institution: Gail Gates, PhD, RD/LD Oklahoma State University Date
More informationBone Basics National Osteoporosis Foundation 2013
When you have osteoporosis, your bones become weak and are more likely to break (fracture). You can have osteoporosis without any symptoms. Because it can be prevented and treated, an early diagnosis is
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS IN THE TREATMENT OF PRIMARY OSTEOPOROSIS
European Medicines Agency London, 16 November 2006 Doc. Ref. CPMP/EWP/552/95 Rev. 2 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS IN THE TREATMENT
More informationPRACTICAL DENSITOMETRY
PRACTICAL DENSITOMETRY The Challenge of Osteoporosis Osteoporosis is a silent disease that develops over decades Goal: identify patients with osteoporosis before fractures occur Means: measure bone density
More informationRecent Topics in Treatment of Osteoporosis
Review Article Recent Topics in Treatment of Osteoporosis JMAJ 49(9 10): 309 314, 2006 Satoshi Soen* 1 Abstract It has come to light that osteoporosis-related fractures are more critical than previously
More informationVitamin D (serum, plasma)
Vitamin D (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Vitamin D 1.2 Alternative names The term vitamin D covers a group of closely related naturally occurring lipid soluble compounds
More informationVitamin D status: effects on parathyroid hormone and 1,25-dihydroxyvitamin D in postmenopausal women 1,2
Vitamin D status: effects on parathyroid hormone and 1,25-dihydroxyvitamin D in postmenopausal women 1,2 Allan G Need, Michael Horowitz, Howard A Morris, and BE Christopher Nordin ABSTRACT Background:
More informationVitamin D, Parathyroid Hormone, and Bone Mineral Density Status in Kidney Transplant Recipients
Transplantation Vitamin D, arathyroid Hormone, and Bone Mineral Density Status in Kidney Transplant Recipients Shokoufeh Savaj, Farinaz J Ghods Firoozgar Hospital, Tehran University of Medical Sciences,
More informationDiabetic Nephropathy
Diabetic Nephropathy Kidney disease is common in people affected by diabetes mellitus Definition Urinary albumin excretion of more than 300mg in a 24 hour collection or macroalbuminuria Abnormal renal
More informationInsulin Resistance and PCOS: A not uncommon reproductive disorder
Insulin Resistance and PCOS: A not uncommon reproductive disorder Joyce L. Ross, MSN, CRNP, CS, FNLA, FPCNA Diplomate Accrediation Council for Clinical Lipidology President Preventive Cardiovascular Nurses
More informationNutrition for Family Living
Susan Nitzke, Nutrition Specialist; susan.nitzke@ces.uwex.edu Sherry Tanumihardjo, Nutrition Specialist; sherry.tan@ces.uwex.edu Amy Rettammel, Outreach Specialist; arettamm@facstaff.wisc.edu Betsy Kelley,
More informationVitamin D. Sources of vitamin D
1 has been in the news frequently this past year, including an article in The New York Times on November 16, 2009. So what is this vitamin? Why is it important? Most people have heard that vitamin D is
More informationThe Prevalence and Determinants of Undiagnosed and Diagnosed Type 2 Diabetes in Middle-Aged Irish Adults
The Prevalence and Determinants of Undiagnosed and Diagnosed Type 2 Diabetes in Middle-Aged Irish Adults Seán R. Millar, Jennifer M. O Connor, Claire M. Buckley, Patricia M. Kearney, Ivan J. Perry Email:
More informationCMAJ JAMC. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada
CANADIAN M EDICAL A SSOCIATION J OURNAL J OURNAL DE L ASSOCIATION MÉDICALE CANADIENNE CMAJ JAMC 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada CMAJ 2002;167(10
More informationOsteoporosis. The inside looks like honeycomb, with blood vessels and bone marrow in the spaces between bone.
Osteoporosis The bones in our skeleton are made of a thick outer shell and a strong inner mesh filled with collagen (protein), calcium salts and other minerals. Osteoporosis The inside looks like honeycomb,
More information16. ARTHRITIS, OSTEOPOROSIS, AND CHRONIC BACK CONDITIONS
16. ARTHRITIS, OSTEOPOROSIS, AND CHRONIC BACK CONDITIONS Goal Reduce the impact of several major musculoskeletal conditions by reducing the occurrence, impairment, functional limitations, and limitation
More informationFRAX Identifying people at high risk of fracture
FRAX Identifying people at high risk of fracture WHO Fracture Risk Assessment Tool, a new clinical tool for informed treatment decisions Authored by Dr. Eugene McCloskey International Osteoporosis Foundation
More informationChronic Kidney Disease and the Electronic Health Record. Duaine Murphree, MD Sarah M. Thelen, MD
Chronic Kidney Disease and the Electronic Health Record Duaine Murphree, MD Sarah M. Thelen, MD Definition of Chronic Kidney Disease (CKD) Defined by the National Kidney Foundation Either a decline in
More informationVitamin D and Calcium: A Systematic Review of Health Outcomes (Update) Executive Summary
Evidence Report/Technology Assessment Number 217 Vitamin D and Calcium: A Systematic Review of Health Outcomes (Update) Executive Summary Background In 2009, the Tufts Evidence-based Practice Center (EPC)
More informationImproving cardiometabolic health in Major Mental Illness
Improving cardiometabolic health in Major Mental Illness Dr. Adrian Heald Consultant in Endocrinology and Diabetes Leighton Hospital, Crewe and Macclesfield Research Fellow, Manchester University Metabolic
More informationOsteoporosis/Bone Health in Adults as a National Public Health Priority
Position Statement Osteoporosis/Bone Health in Adults as a National Public Health Priority This Position Statement was developed as an educational tool based on the opinion of the authors. It is not a
More informationRenal cell carcinoma and body composition:
Renal cell carcinoma and body composition: Results from a case-control control study Ryan P. Theis, MPH Department of Epidemiology and Biostatistics College of Public Health and Health Professions University
More informationPOPULATION BASED REFERENCE STANDARDS OF PEAK BONE MINERAL DENSITY OF INDIAN MALES AND FEMALES - AN ICMR MULTI-CENTRE TASK FORCE STUDY
POPULATION BASED REFERENCE STANDARDS OF PEAK BONE MINERAL DENSITY OF INDIAN MALES AND FEMALES - AN ICMR MULTI-CENTRE TASK FORCE STUDY Indian Council of Medical Research Department of Health Research (Ministry
More informationThe evidencebehindthe increased NordicNutritionRecommendations for vitamind. Christel Lamberg-Allardt University of Helsinki
The evidencebehindthe increased NordicNutritionRecommendations for vitamind Christel Lamberg-Allardt University of Helsinki Aimsfor NutritionRecommendations Aimsfor vitamind The overall aim was to review
More informationHow To Take A Bone Marrow Transplant
Drug treatments to protect your bones This information is an extract from the booklet, Bone health. You may find the full booklet helpful. We can send you a copy free see page 5. Contents Bisphosphonates
More informationEndocrine issues in FA SUSAN R. ROSE CINCINNATI CHILDREN S HOSPITAL MEDICAL CENTER
Endocrine issues in FA SUSAN R. ROSE CINCINNATI CHILDREN S HOSPITAL MEDICAL CENTER 80% of children and adults with FA have an endocrine abnormality Endocrine cells make a hormone (message) Carried in bloodstream
More informationParathyroid hormone (serum, plasma)
Parathyroid hormone (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Parathyroid hormone (PTH) 1.2 Alternative names Parathormone 1.3 NMLC code 1.4 Description of analyte PTH is an
More informationGP Guidance: Management of nutrition following bariatric surgery
GP Guidance: Management of nutrition following bariatric surgery Introduction Patients who are morbidly obese will have struggled with their weight for many years before going forward for bariatric surgery.
More informationBONE MINERAL DENSITOMETRY REPORTING
CAR TECHNICAL STANDARDS FOR BONE MINERAL DENSITOMETRY REPORTING APPROVED: JANUARY 25, 2013 KERRY SIMINOSKI, MD, FRCPC; MARGARET O'KEEFFE, MD, FRCPC; JACQUES P. BROWN, MD, FRCPC; STEVEN BURRELL, MD, FRCPC;
More informationMortality Assessment Technology: A New Tool for Life Insurance Underwriting
Mortality Assessment Technology: A New Tool for Life Insurance Underwriting Guizhou Hu, MD, PhD BioSignia, Inc, Durham, North Carolina Abstract The ability to more accurately predict chronic disease morbidity
More informationTitle:Vitamin D deficiency among admitted patients with acute stroke: a cross -sectional study at a national referral hospital in Kampala, Uganda.
Reviewer's report Title:Vitamin D deficiency among admitted patients with acute stroke: a cross -sectional study at a national referral hospital in Kampala, Uganda. Version:2Date:6 May 2015 Reviewer:Andre
More informationKIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA
KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA O.E. Stakhvoskyi, E.O. Stakhovsky, Y.V. Vitruk, O.A. Voylenko, P.S. Vukalovich, V.A. Kotov, O.M. Gavriluk National Canсer Institute,
More informationA study to Evaluate PPI s effect on vitamin D levels. Rani Hanna M.D., M.S. PGY-3 Joseph Grisanti, MD
A study to Evaluate PPI s effect on vitamin D levels Rani Hanna M.D., M.S. PGY-3 Joseph Grisanti, MD The sunshine vitamin Existed over 500 million years. Prehormone, not only a vitamin. Two major sources:
More informationCoronary Heart Disease (CHD) Brief
Coronary Heart Disease (CHD) Brief What is Coronary Heart Disease? Coronary Heart Disease (CHD), also called coronary artery disease 1, is the most common heart condition in the United States. It occurs
More informationVascular Risk Reduction: Addressing Vascular Risk
Vascular Risk Reduction: Addressing Vascular Risk Vascular Risk Reduction (VRR) Welcome! Presentation & Activities Focus: Managing known risk factors for vascular disease. Engage, collaborate and have
More informationEstimated GFR Based on Creatinine and Cystatin C
Estimated GFR Based on Creatinine and Cystatin C Lesley A Stevens, MD, MS Tufts Medical Center, Tufts University School of Medicine Boston MA Chronic Kidney Disease-Epidemiology Collaboration UO1 DK 053869,
More informationThe threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism
European Journal of Endocrinology (2005) 153 373 378 ISSN 0804-4643 CLINICAL STUDY The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism Hiroshi
More informationMain Effect of Screening for Coronary Artery Disease Using CT
Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,
More informationAbsolute cardiovascular disease risk assessment
Quick reference guide for health professionals Absolute cardiovascular disease risk assessment This quick reference guide is a summary of the key steps involved in assessing absolute cardiovascular risk
More informationNATIONAL OSTEOPOROSIS FOUNDATION OSTEOPOROSIS CLINICAL UPDATES Rehabilitation of Patients With Fragility-Related Fractures CE APPLICATION FORM
NATIONAL OSTEOPOROSIS FOUNDATION OSTEOPOROSIS CLINICAL UPDATES Rehabilitation of Patients With Fragility-Related Fractures CE APPLICATION FORM First Name: Last Name: Mailing Address: City: State: Zip/Postal
More informationDrug treatment pathway for Osteoporosis in Postmenopausal Women
Drug treatment pathway for Osteoporosis in Postmenopausal Women Version 1.0 Ratified by: East Sussex HEMC Date ratified: 26.01.2011 Job title of originator/author Gillian Ells, East Sussex HEMC Pharmacist
More informationDiabetes and Your Kidneys
American Kidney Fund reaching out giving hope improving lives Diabetes and Your Kidneys reaching out giving hope improving lives Diabetes: The #1 Cause of Kidney Failure Your doctor told you that you have
More information嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯
The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors in Adults with Type 2 Diabetes Mellitus 嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 Diabetes Mellitus : A group of diseases characterized
More informationMetabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007
Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering
More informationCalculating the stage of Renal Disease
Calculating the stage of Renal Disease When the Refresh Template/Check Labs button is depressed, the box next to MDRD, will be automatically checked. In order to use this in the calculation of the stage
More informationVitamin D deficiency: the cause of everything?
Health problems linked to vitamin D deficiency: Vitamin D deficiency: the cause of everything? Louise Gagné M.D. Family Physician Saskatoon Community Clinic Clinical Assistant Professor Department of Community
More informationHDL Cholesterol Subfractions and the Effect of Testosterone Replacement in Hypogonadism
HDL Cholesterol Subfractions and the Effect of Testosterone Replacement in Hypogonadism E. Bolu 1, A. Sonmez 1, S. Tapan 2, A. Taslipinar 1, A. Aydogdu 1, C. Meric 1, Y. Basaran 1, G. Uckaya 1, M. Serdar
More informationVitamin K 2 treatment for postmenopausal osteoporosis in Indonesia
Blackwell Publishing AsiaMelbourne, AustraliaJOGThe Journal of Obstetrics and Gynaecology Research1341-87626 Asia and Oceania Federation of Obstetrics and Gynaecology2632223234Original ArticleVitamin K2
More informationPHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.
PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. Hossam Bahy, MD (1992 2012), 19 tools have been identified 11 stroke scores 1
More informationKDIGO. Active and Native Vitamin D
Active and Native Vitamin D KDIGO Grahame Elder Department of Renal Medicine, Westmead Hospital Osteoporosis & Bone Biology Division, Garvan Institute of Medical Research, Sydney Disclosures Member of
More informationMedicare s Preventive Care Services. Manage Your Chronic Kidney Disease (CKD stages 3-4) with Diet
s Preventive Care Services Manage Your Chronic Kidney Disease (CKD stages 3-4) with Diet What do the kidneys do? Your kidneys have important jobs to do in your body. Two of the kidneys most important jobs
More informationBody Composition & Longevity. Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ
Body Composition & Longevity Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ LONGEVITY Genetic 25% Environmental Lifestyle Stress 75% BMI >30 OBESE 25-30 OVERWEIGHT 18-25 NORMAL WEIGHT 18
More informationOST and BMD Risk Assessment in Morocco
DOI 10.1007/s10067-007-0611-4 ORIGINAL ARTICLE Performance of the osteoporosis risk assessment tool in Moroccan men Mirieme Ghazi & Aziza Mounach & Abderrazak Nouijai & Imad Ghozlani & Loubna Bennani &
More informationCardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011
Cardiovascular disease physiology Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011 Content Introduction The number 1 killer in America Some statistics Recommendations The disease process
More informationObesity in the United States Workforce. Findings from the National Health and Nutrition Examination Surveys (NHANES) III and 1999-2000
P F I Z E R F A C T S Obesity in the United States Workforce Findings from the National Health and Nutrition Examination Surveys (NHANES) III and 1999-2000 p p Obesity in The United States Workforce One
More informationThe WHI 12 Years Later: What Have We Learned about Postmenopausal HRT?
AACE 23 rd Annual Scientific and Clinical Congress (2014) Syllabus Materials: The WHI 12 Years Later: What Have We Learned about Postmenopausal HRT? JoAnn E. Manson, MD, DrPH, FACP, FACE Chief, Division
More informationBarriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness
Barriers to Healthcare Services for People with Mental Disorders Cardiovascular disorders and diabetes in people with severe mental illness Dr. med. J. Cordes LVR- Klinikum Düsseldorf Kliniken der Heinrich-Heine-Universität
More informationHealth risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study
DOI 10.1007/s00198-012-2224-2 ORIGINAL ARTICLE Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study R. L. Prentice & M. B. Pettinger
More informationVitamin D in Infancy, Childhood and Adolescence
Vitamin D in Infancy, Childhood and Adolescence Christopher Kovacs, MD, FRCPC, FACP Professor of Medicine (Endocrinology) Memorial University of Newfoundland ckovacs@mun.ca Disclosure I am currently serving
More informationUCSF Kidney Transplant Symposium 2012
UCSF Kidney Transplant Symposium 2012 Nutrition Fitness in Kidney Transplant Mary Ellen DiPaola, RD, CDE UCSF Outpatient Dietitian Goal of Nutrition Fitness for Transplant Nutritional guidance of pre-
More informationThe National Center for Health Statistics' Linked Data Files: Resources for Research and Policy. Eric A. Miller National Center for Health Statistics
The National Center for Health Statistics' Linked Data Files: Resources for Research and Policy Eric A. Miller National Center for Health Statistics NCHS Record Linkage Program Links survey data with data
More informationNova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines)
Cardiovascular Health Nova Scotia Guideline Update Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines) Authors: Dr. M. Love, Kathy Harrigan Reviewers:
More informationSelected Questions and Answers on Vitamin D
Selected Questions and Answers on Vitamin D Joint FAQs to the BfR, German Nutrition Society (DGE) und Max Rubner-Institute (MRI) of 03 December 2014 1 Vitamin D promotes the intake of calcium from the
More informationTreatment of diabetes In order to survive, people with type 1 diabetes must have insulin delivered by a pump or injections.
National Diabetes Statistics What is diabetes? Diabetes mellitus is a group of diseases characterized by high levels of blood glucose resulting from defects in insulin production, insulin action, or both.
More informationCardiovascular Risk in Diabetes
Cardiovascular Risk in Diabetes Lipids Hypercholesterolaemia is an important reversible risk factor for cardiovascular disease and should be tackled aggressively in all diabetic patients. In Type 1 patients,
More informationUnderstanding diabetes Do the recent trials help?
Understanding diabetes Do the recent trials help? Dr Geoffrey Robb Consultant Physician and Diabetologist CMO RGA UK Services and Partnership Assurance AMUS 25 th March 2010 The security of experience.
More informationMarilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL
Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL www.goldcopd.com GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR DIAGNOSIS, MANAGEMENT
More informationOsteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis. Disclosure and Conflicts of Interest Steven T Harris MD 2014-2015
Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis Steven T Harris MD FACP Clinical Professor of Medicine University of California, San Francisco steve.harris@ucsf.edu Disclosure
More informationLoss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women
Eur J Epidemiol (2009) 24:707 712 DOI 10.1007/s10654-009-9381-4 LOCOMOTOR DISEASES Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal
More information